Grant of Options

RNS Number : 0739P
Futura Medical PLC
28 September 2011
 



 

For immediate release

28 September 2011

 

 

Futura Medical plc

("Futura" or "the Company")

Grant of Options

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that on 28 September 2011 it granted options over a total of 700,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.

Director

Number of options granted

Exercise price

Exercise period

Total number of options held following notification

Total number of ordinary shares held







W D Potter

100,000

56.50p

1 Oct 2013 - 30 Sep 2018

300,000

207,424

J H Barder

250,000

56.50p

1 Oct 2013 - 30 Sep 2018

700,000

870,330

D B Davies

200,000

56.50p

1 Oct 2013 - 30 Sep 2018

600,000

631,306

D A Martin

150,000

56.50p

1 Oct 2013 - 30 Sep 2018

550,000

225,000

 

All options were granted under the Futura Medical plc Unapproved Share Option Scheme with the exception of 73,894 options granted to D A Martin which were granted under the Futura Medical plc Enterprise Management Incentive Scheme.

 

The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.

 

For any further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

 

 

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 

Nomura Code Securities Limited

 

Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200

 

 

For media enquiries please contact:

 

 

 

Buchanan Communications

 

Mark Court / Jessica Fontaine

Tel: +44 (0) 20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIFLEALITFIL
UK 100

Latest directors dealings